Not applicableUnknownNCT04568044What this trial is testingEvaluation of Humoral Immunity Following COVID-19 in PregnancyWho this might be right forCOVID-19Pregnancy RelatedInfluenza, Human Imperial College London 128
Early research (Phase 1)Study completedNCT00117429What this trial is testingStudy of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)Who this might be right forHIV Infections Marcus Altfeld, M.D., Ph.D. 20
Not applicableUnknownNCT04473131What this trial is testingImmune Profiling of COVID19-patients Admitted to ICUWho this might be right forCOVID-19 Hamad Medical Corporation 300
Not applicableStudy completedNCT01765413What this trial is testingTraining Study to Characterize Biomarkers to Chickenpox and Yellow Fever VaccinesWho this might be right forHealthy University of Surrey 48
Post-approval studies (Phase 4)Study completedNCT00304382What this trial is testingHumoral Determinants of Immunity to Pneumococcal InfectionWho this might be right forPneumoniaPneumococcal InfectionsInfections, Streptococcus Pneumoniae VA Office of Research and Development 114
Not applicableUnknownNCT04728763What this trial is testingAspergillosis and Humoral Alveolar Immunity by ProteomicsWho this might be right forAspergillus Fumigatus Infection Assistance Publique - Hôpitaux de Paris 32
Not applicableStudy completedNCT00001158What this trial is testingStudies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune SystemWho this might be right forImmunologic Deficiency SyndromesNeoplasms National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538915What this trial is testingOpen Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)Who this might be right forPrimary Immune Deficiency Disorders (PIDD) ADMA Biologics, Inc. 63
Large-scale testing (Phase 3)Ended earlyNCT00647465What this trial is testingEffect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing AnswerWho this might be right forInfluenza Infection Assistance Publique - Hôpitaux de Paris 140
Not applicableUnknownNCT03228069What this trial is testingImmune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected AdultsWho this might be right forRabies Queen Saovabha Memorial Institute 40
Not applicableStudy completedNCT04615026What this trial is testingPrevalence of Thrombosis in COVID-PatientsWho this might be right forCovid19 University Hospital Augsburg 525
Not applicableUnknownNCT04924855What this trial is testingImmunity After COVID-19 VaccinationWho this might be right forTunis Military Hospital Staff Vaccinated Against Covid 19 General Administration of Military Health, Tunisia 300
Not applicableStudy completedNCT04858607What this trial is testingHumoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy IndividualsWho this might be right forCovid19Immunosuppression Medical University of Graz 373
Post-approval studies (Phase 4)Study completedNCT02408926What this trial is testingVaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in ThailandWho this might be right forPertussis Universiteit Antwerpen 370
Not applicableUnknownNCT02933723What this trial is testingImmunogenicity of Influenza Vaccine in Long Term CareWho this might be right forInfluenza Insight Therapeutics, LLC 200
Post-approval studies (Phase 4)Study completedNCT01811823What this trial is testingEffect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in AdultsWho this might be right forInfluenzaHIVTuberculosis University of Witwatersrand, South Africa 301
Large-scale testing (Phase 3)Study completedNCT05479370What this trial is testingImmunogenicity Trial of 3 Influenza VaccinesWho this might be right forInfluenza Vaccination Tan Tock Seng Hospital 366
Not applicableStudy completedNCT04837651What this trial is testingHumoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabWho this might be right forMultiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous System+5 more Dragonfly Research, LLC 48
Not applicableLooking for participantsNCT03323112What this trial is testingImmune Responses in Health Care PersonnelWho this might be right forInfluenza Finnish Institute for Health and Welfare 150
Not applicableNot Yet RecruitingNCT07436780What this trial is testingB Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP (Ventilator-Associated Pneumonia)Who this might be right forVentilator-associated Pneumonia University Hospital, Limoges 75